Exhibit 10.1

      

      
        

        

        Certain confidential information contained in this document, marked by brackets and asterisk, has been 

        omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be 

        competitively harmful if publicly disclosed.

        

        

      

       AMENDMENT NO. 4 TO RESEARCH COLLABORATION AGREEMENT

      

      

      This Amendment No. 4 to Research Collaboration Agreement (this “Amendment”) is entered into as of this 14th day of October, 2021 (the “Amendment Date”),
        by and between President and Fellows of Harvard College, a charitable corporation of Massachusetts having an office at Richard A. and Susan F.
        Smith Campus Center, Suite 727, 1350 Massachusetts Avenue, Cambridge, Massachusetts 02138 (“Harvard”), and ReWalk Robotics, Ltd. a company existing under the laws of the State
        of Israel, having a place of business at 200 Donald Lynch Blvd., Marlborough, MA 01752 (“Company”).  Harvard and Company each shall be referred
        to herein as a “Party” and together as the “Parties.”

      

      

      WHEREAS, Harvard

        and Company entered into a Research Collaboration Agreement, dated as of May 16, 2016, as previously amended on May 1, 2017, April 1, 2018, and April 30, 2020 (the “RCA” or “Research Collaboration Agreement”); and

       

      WHEREAS, Harvard

        and Company desire to amend the RCA as set forth below in accordance with Section 10.9 of the RCA.

      

      

      NOW, THEREFORE,
        for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

       

      	I.	
              Amendments to the RCA.  Effective as of the Amendment Date:

            


       

      	

            	A.	
              Costs and Expenses.  The RCA is hereby amended by deleting
                existing Sections 3.1.6 through 3.1.8 in their entirety
                and replacing them with the following new Sections 3.1.6 and 3.1.7,
                each to read as follows:

            


       

      “3.1.6          [*] United States Dollars (US $[*])
          for 2021 to be paid as follows: one (1) initial quarterly installment of [*] United States Dollars and (US $[*]) and three (3) subsequent quarterly installments of [*] United States Dollars (US $[*]), each of which shall be payable within forty-five (45) days of receipt of the invoice from Harvard for such amount. Where practicable, Harvard shall issue each invoice to Company at
          least five (5) days prior to the start of each Calendar Quarter in 2021.

       

      3.1.7          [*] United States Dollars (US $[*])
          for 2022 to be paid as follows: one installment of [*] United States Dollars (US $[*]),

          which shall be payable within forty-five (45) days of receipt of the invoice from Harvard for such amount.  Harvard shall issue such invoice to Company at least five (5) days prior to the start of the first Calendar Quarter in 2022.”

       

      	

            	B.	
              Term.  The RCA is hereby amended by deleting the existing Section 9.1 in its entirety and replacing it with the following new Section

                    9.1 to read as follows:

            


       

      “9.1          Term.  This Agreement shall commence on the Effective Date and shall remain in effect until March 31, 2022 (the “Term”), unless earlier terminated in accordance with the provisions of this Article 9.  Further to the foregoing, the Parties agree to meet in January 2022 to discuss the Research Plan and a potential extension of the RCA beyond the Term as set forth in this Agreement.

       

      
        
          


      

      
      	

            	C.	
              Research Plan.  The RCA is hereby amended by deleting the
                existing Exhibit A in its entirety and replacing it with the new Exhibit A attached to this Amendment.

            


       

      	II.	
              Capitalized terms used but not otherwise defined in this Amendment shall have the respective meanings ascribed to such terms in the RCA.

            


       

      	III.	
              Except as expressly amended hereby, all other terms of the RCA shall remain unchanged and in full force and effect in accordance therewith.

            


       

      	IV.	
              This Amendment will be governed by, and construed in accordance with, the substantive laws of the Commonwealth of Massachusetts, without giving effect to any choice
                or conflict of law provision.

            


       

      	V.	
              The Parties may execute this Amendment in two or more counterparts, each of which shall be deemed an original, but both of which together shall constitute one and the
                same instrument.  Transmission by facsimile or electronic mail of an executed counterpart of this Amendment shall be deemed to constitute due and sufficient delivery of such counterpart.  If by electronic mail, the executed Amendment must
                be delivered in a .pdf format.

            


       

      ** Signature Page Follows **

      

      

      
        2

        
          


      

      IN

          WITNESS WHEREOF, each Party has caused this Amendment to be executed by its duly authorized representative as of the Amendment Effective Date.

      

      

      	
              President and Fellows of Harvard College

               

              

              By: /s/ Isaac Kohlberg

               

              

              Name: Isaac T. Kohlberg

               

              

              Title:  Senior Associate Provost

              Chief Technology Development Officer

              Office of Technology Department

              Harvard University

               

              

              I, the undersigned, hereby confirm that I
                have read this Amendment, including the Research Plan included in this Amendment, that its contents are acceptable to me and that I will act in accordance with its terms.

               

                

              /s/ Conor J. Walsh

                Conor J. Walsh, Ph.D.

            	
              ReWalk Robotics, Ltd.

               

              

              By: /s/
                    Larry Jasinski

              Name: Larry Jasinski

              Title: Chief Executive Officer

            


      

      

      
        3

        
          


      

      SCHEDULE I

      

      

      Exhibit A

      

      

      Research Plan

      

      

      	Aim:	
              Harvard expects to perform research to support Company’s development of stroke specific Soft Exosuits as follows for the Term as defined above:

            


      

      

      [*]

      

      

    

  

  4